Gelatinase (MMP-2/9) in Pathogen Virulence: Tissue Invasion, Immune Evasion, and Biofilm Modulation

Gelatinases (Matrix Metalloproteinases-2 and -9) degrade denatured collagen (gelatin), native collagen IV/V, elastin, and laminin — key basement membrane and extracellular matrix (ECM) components.

Virulence Mechanisms

  • Tissue invasion: ECM degradation breaches basement membranes → hematogenous/lymphatic dissemination (e.g., Pseudomonas aeruginosa, Staphylococcus aureus, Clostridium spp., Vibrio vulnificus).
  • Nutrient acquisition: Liberates peptides/amino acids from ECM proteins → supports bacterial growth in nutrient-poor niches.
  • Biofilm modulation: MMPs process biofilm matrix proteins; can promote initial attachment or facilitate dispersal. Context-dependent.
  • Immune evasion: Cleave immunoglobulins (IgG, IgA), complement components (C3b, C5a), cytokines (IL-1β, TNF-α), antimicrobial peptides (LL-37) → blunts opsonization, chemotaxis, direct killing.
  • Barrier disruption: Degrade tight junction proteins (claudins, occludin) → paracellular leak, bacterial translocation.
  • Toxin activation: Some pathogens (e.g., V. vulnificus) secrete gelatinase that processes pro-toxins or acts as toxin itself (cytolytic).

Therapeutic Implications

  • MMP inhibitors (doxycycline, batimastat, marimastat) — limited clinical success due to musculoskeletal toxicity.
  • Antibody-based neutralization (experimental).
  • Targeting pathogen secretion systems (T2SS, T1SS) that export gelatinases.

Gelatinase production is a hallmark of invasive, tissue-destructive pathogens across bacterial and fungal kingdoms.

Genetic Disorders - Related Articles